Hannah Yang

University of Michigan

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (12)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (8)

Seul-Gi Kim

Clinical Associate Professor

CHA Bundang Medical Center

SOUTH KOREA

View details

Hong Jae Chon

Associate Professor

CHA Bundang Medical Center

SOUTH KOREA

View details

Chang Woo Kim

Professor

Ajou University School of Medicine

SOUTH KOREA

View details

Sung Hwan Lee

CHA University

SOUTH KOREA

View details

ilhwan kim

Associate Professor

Inje University Ilsan Paik Hospital

SOUTH KOREA

View details

Sanghoon Jung

Assistant Professor

CHA Bundang Medical Center

SOUTH KOREA

View details

Wooram Park

Assistant Professor

Sungkyunkwan University

SOUTH KOREA

View details

Chan Kim

Assistant Professor

CHA University School of Medicine

SOUTH KOREA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hannah Yang

Research Interests

Explore related searches

Contact this professor

Articles (12)

Oral reovirus reshapes the gut microbiome and enhances antitumor immunity in colon cancer

Systemic Delivery of a STING Agonist-Loaded Positively Charged Liposome Selectively Targets Tumor Immune Microenvironment and Suppresses Tumor Angiogenesis.

High levels of baseline serum IL-10 are associated with reduced clinical benefit from first-line immune checkpoint inhibitor therapy in advanced renal cell carcinoma.

High serum IL-6 correlates with reduced clinical benefit of atezolizumab and bevacizumab in unresectable hepatocellular carcinoma.

PB101, a VEGF- and PlGF-targeting decoy protein, enhances antitumor immunity and suppresses tumor progression and metastasis

High Serum Levels of IL-6 Predict Poor Responses in Patients Treated with Pembrolizumab plus Axitinib for Advanced Renal Cell Carcinoma.

Association of High Levels of Antidrug Antibodies Against Atezolizumab With Clinical Outcomes and T-Cell Responses in Patients With Hepatocellular Carcinoma.

Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade.

Deep learning model enables the discovery of a novel immunotherapeutic agent regulating the kynurenine pathway.

High endothelial venule is a surrogate biomarker for T-cell inflamed tumor microenvironment and prognosis in gastric cancer.

Integrin αvβ3 Induces HSP90 Inhibitor Resistance via FAK Activation in KRAS-Mutant Non-Small Cell Lung Cancer.

STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer.

Collaborators (8)

Seul-Gi Kim

Hong Jae Chon

Chang Woo Kim

Sung Hwan Lee

ilhwan kim

Sanghoon Jung

Wooram Park

Chan Kim

Make your next move.